To include your compound in the COVID-19 Resource Center, submit it here.

Boehringer Ingelheim, Bristol-Myers infectious news

The Medicines Patent Pool said it began negotiations for patents to HIV drugs from Boehringer and Bristol-Myers. The pool, established

Read the full 204 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE